Nitrostat (sublingual nitroglycerin) is a prescription nitrate used to prevent and relieve angina pectoris in adults by relaxing blood vessels and decreasing cardiac workload. It’s supplied as sublingual tablets in 0.3 mg, 0.4 mg and 0.6 mg strengths and as lingual sprays at 400 mcg per spray, giving clinicians and patients options for rapid onset treatment when chest pain starts. The primary target user is an adult with documented coronary artery disease who requires on‑demand relief of ischemic chest pain.
This review synthesizes information from clinical and reference sources included in our brief: Mayo Clinic, Cleveland Clinic, WebMD, Drugs.com, Healthline and GoodRx. Data pulled from those sources include available formulations and strengths, recommended routes (sublingual or lingual), storage recommendations (room temperature ranges), and commonly reported adverse effects and clinical warnings.
High‑level verdict: Nitrostat performs well as a rapid, effective antianginal rescue medication — it provides near‑immediate symptomatic relief when used sublingually or as a spray and is available in multiple strengths (0.3–0.6 mg tablets, 400 mcg/spray). The tradeoffs are predictable and dose‑related: common side effects include headache and low blood pressure with dizziness or fainting, and there are practical storage and handling requirements (keep tablets in original glass container, store at ~20–25°C). Overall it’s an indispensable tool for acute angina but requires patient education and clinical oversight.
Does sublingual nitroglycerin relieve angina quickly?
Yes — when used sublingually or as a lingual spray nitroglycerin delivers nitrate to the bloodstream rapidly and is intended for immediate relief of angina. Sources describe placing a tablet under the tongue or using a lingual aerosol; tablet strengths are 0.3 mg, 0.4 mg and 0.6 mg and sprays deliver 400 mcg (0.4 mg) per actuation, enabling quick vascular smooth muscle relaxation and reduced cardiac workload.
Clinical reference sources (Mayo Clinic, Cleveland Clinic, WebMD) list sublingual nitroglycerin as a standard on‑demand treatment for chest pain caused by coronary artery disease, reflecting long clinical experience with its efficacy for acute ischemic symptoms.
What formulations and doses are available?
Nitroglycerin for oral/sublingual use is available as small sublingual tablets in 0.3 mg, 0.4 mg and 0.6 mg strengths and as lingual aerosol sprays delivering 400 mcg (0.4 mg) per spray. The spray and tablet options offer flexibility for patient preference and ability to dissolve medication quickly in the oral mucosa.
The product is prescription only and comes in several brand names (Nitrostat, NitroMist, Nitrolingual Pumpspray, Nitroquick, Nitrotab) and generic formulations; choice of tablet versus spray can affect ease of use in patients who have difficulty keeping a tablet under the tongue or need a metered aerosol dose.
Side effects and clinical warnings you must know
Common adverse effects documented across our references include headache, low blood pressure (hypotension) leading to lightheadedness, dizziness and potential fainting. Healthline and WebMD specifically flag low blood pressure and related symptoms as common risks; Cleveland Clinic and Mayo Clinic emphasize discussing pre‑existing conditions with a clinician.
Sources list conditions that clinicians should be informed about before prescribing nitroglycerin: anemia, recent head injury, recent stroke or intracranial bleeding, liver disease and prior myocardial infarction are named as relevant medical history items to disclose. Pediatric studies are reported as not performed for the oral/sublingual route.
How sensitive is nitroglycerin to storage and handling?
Tablets should be stored at room temperature; WebMD specifies 68°F to 77°F (20°C to 25°C) as a target range and allows short exposures between 59°F and 86°F (15°C to 30°C) during transport. Sublingual tablets are commonly supplied in glass containers and should be kept in the original glass bottle with the lid closed tightly after each use.
These storage requirements matter because improper storage (exposure to heat, humidity, or light) can reduce potency of sublingual nitrates; patients should follow packaging instructions and prescriber/pharmacist guidance to preserve effectiveness.
Real‑world practicality: portability, dosing flexibility, and patient education
The spray form (400 mcg per spray) is convenient and portable for many patients, while tablets in three strengths allow clinicians to tailor dose size. Because side effects like headache and hypotension are common, patient counseling is essential — users need to know how the medicine is taken (sublingually or lingually), its intended rapid onset, and the potential for dizziness or fainting.
Storage in original glass containers and keeping the product at recommended temperatures reduces risk of reduced potency; the prescription‑only status means initiation and follow‑up occur under clinical supervision.
Pros & Cons
- ✅ Rapid onset when used sublingually or as a lingual spray (intended for immediate angina relief)
- ✅ Multiple tablet strengths available: 0.3 mg, 0.4 mg, 0.6 mg, plus lingual spray at 400 mcg per spray for dosing flexibility
- ✅ Widely referenced and established therapy for angina in major clinical sources (Mayo Clinic, Cleveland Clinic, WebMD)
- ✅ Portable spray option (400 mcg/spray) for patients who cannot keep a tablet under the tongue
- ❌ Common side effects include headache and low blood pressure; can cause dizziness and fainting in some patients
- ❌ Tablets must be kept in original glass container and stored at about 20–25°C (68–77°F), which limits rough handling and exposure to heat
- ❌ Not studied in pediatric populations for the oral/sublingual route according to reference sources
How It Compares to the Competition
- Nitrolingual Pumpspray — Metered lingual aerosol delivering 400 mcg per spray — similar rapid action to Nitrostat spray, useful when a precise single‑spray dose is preferred.
- NitroMist — Another lingual aerosol option with comparable on‑demand delivery; choice is largely patient preference between specific spray devices.
- Nitroquick (sublingual tablets) — Sublingual tablet brand available in comparable tablet strengths — same route and clinical role as Nitrostat for immediate angina relief.
- Nitrotab — Brand that includes sublingual and other nitroglycerin formulations; options vary by form factor and dosing needs.
Who Should Buy This & Who Should Skip It
Buy it if: Adults with documented coronary artery disease who need an on‑demand, rapid‑acting treatment for angina should consider sublingual nitroglycerin in discussion with their clinician. Patients who prefer a portable, meterable dose may prefer the 400 mcg spray, while those who want varying tablet strengths can choose 0.3–0.6 mg tablets.
Skip it if: People with recent head injury, recent stroke or intracranial bleeding, a history of marked hypotension, or significant untreated anemia should consult their care team before using nitroglycerin; pediatric patients are not covered by oral/sublingual studies in the referenced sources. Patients who cannot adhere to storage instructions (original glass container; ~20–25°C) may be better served by supervised alternatives.
Search Purchase Options
Use these links to search for Sublingual nitroglycerin (Nitrostat) on trusted marketplaces. The links open in new tabs; if you buy through them, we may earn a commission at no extra cost to you.
* Affiliate links: you pay the same price either way.